Literature DB >> 4363471

Clinical implications of monoclonal gammopathy in chronic liver disease.

S Slavin, A Zlotnick, I S Levij, M Eliakim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4363471     DOI: 10.1007/bf01072539

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


× No keyword cloud information.
  34 in total

1.  Production of tetanus antitoxin by patients with hepatic cirrhosis.

Authors:  W P HAVENS; R M MYERSON; J KLATCHKO
Journal:  N Engl J Med       Date:  1957-10-03       Impact factor: 91.245

2.  The production of antibody by patients with chronic hepatic disease.

Authors:  W P HAVENS; J M SHAFFER; C J HOPKE
Journal:  J Immunol       Date:  1951-10       Impact factor: 5.422

3.  Cryoglobulinaemia in rabbits hyperimmunized with a polyvalent pneumococcal vaccine.

Authors:  E A Catsoulis; E C Franklin; M A Rothschild
Journal:  Immunology       Date:  1965-10       Impact factor: 7.397

4.  Dysimmunoglobulinemia associated with hepatobiliary disorders.

Authors:  Z Zawadzki; G A Edwards
Journal:  Am J Med       Date:  1970-02       Impact factor: 4.965

5.  Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver.

Authors:  M Bjorneboe; H Prytz; F Orskov
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

6.  Immunoglobulins in chronic liver disease.

Authors:  T Feizi
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

7.  Chronic liver disease associated with mixed cryoglobulinemia. Review of the literature and presentation of two cases.

Authors:  M Eliakim; S Slavin; A Zlotnick
Journal:  Med Chir Dig       Date:  1972

8.  Essential cryoglobulinemia. Immunologic studies before and after penicillamine therapy.

Authors:  L S Goldberg; E V Barnett
Journal:  Arch Intern Med       Date:  1970-01

9.  Increased cellular immunological response in patients with chronic liver disease.

Authors:  M Söborg; N Tygstrup
Journal:  Scand J Gastroenterol Suppl       Date:  1970

10.  Tetanus antitoxin production and gamma globulin levels in patients with cirrhosis of the liver.

Authors:  M Bjorneboe; K B Jensen; I Scheibel; A C Thomsen; M W Bentzon
Journal:  Acta Med Scand       Date:  1970-12
View more
  4 in total

1.  Development of Hodgkin's disease in the course of liver cirrhosis and impaired monocyte function.

Authors:  M Dan; A Hassner; M Jedwab; S Shibolet
Journal:  Postgrad Med J       Date:  1984-07       Impact factor: 2.401

2.  Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.

Authors:  John P Bida; Robert A Kyle; Terry M Therneau; L Joseph Melton; Matthew F Plevak; Dirk R Larson; Angela Dispenzieri; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

3.  Malignant lymphoproliferative disorders in chronic liver disease. Report of four cases and review of the literature.

Authors:  J Naparstek; M Eliakim
Journal:  Am J Dig Dis       Date:  1978-10

4.  Hypergammaglobulinemia in the pediatric population as a marker for underlying autoimmune disease: a retrospective cohort study.

Authors:  Mindy S Lo; David Zurakowski; Mary Beth F Son; Robert P Sundel
Journal:  Pediatr Rheumatol Online J       Date:  2013-11-01       Impact factor: 3.054

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.